Streetbeat News

Equity Actions

ALIT

Alight, Inc has updated its FY23 revenue forecast to $3.47B-$3.51B, representing a growth of 11% to 12%. The company also expects an adjusted EPS of $0.65-$0.69, up from the prior estimate of $0.62-$0.67. Other projections include adjusted EBITDA of $735M-$750M, BPaaS total contract value bookings of $700M-$900M, and an operating cash flow conversion rate of 45-55%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:34 am

TRMB

Trimble Inc. has announced that its CFO, David Barnes, will retire from the company in May 2024. Phil Sawarynski has been named as his successor.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 11:29 am

TRI

Thomson Reuters has announced plans to repurchase up to $1.0 billion of its shares under a new normal course issuer bid (NCIB). The company has received approval from the Toronto Stock Exchange for the renewal of its NCIB. Up to 10 million common shares, representing approximately 2.19% of the company’s issued and outstanding common shares, may be repurchased between November 3, 2023, and November 2, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:50 am

GOOS

Canada Goose has appointed Neil Bowden as its new CFO and Jonathan Sinclair as President of APAC. The changes in the executive team are expected to drive the company's growth strategy.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:46 am

IDXX

IDEXX Laboratories has updated its FY2023 guidance, raising its EPS outlook from $9.64-$9.90 to $9.74-$9.90, while lowering its sales guidance from $3.66B-$3.71B to $3.64B-$3.65B. The company's full year revenue growth outlook range is now 7.9% - 8.4% as reported and 8.3% - 8.8% organically. The overall reported revenue range was decreased by $20 million due to updated foreign exchange impact estimates. The company's operating margin outlook has been raised to 29.6% - 29.8%.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:38 am

AVA

Avista Corp has revised its FY23 EPS guidance to $2.27-$2.37 from the previous $2.27-$2.47. The company's capital expenditures for the nine months ended Sept. 30, 2023, were $347 million, and it plans to spend $475 million for the year. Avista expects to increase its capital expenditures to $500 million in 2024, $525 million in 2025, and $550 million in 2026. It also plans to invest $15 million in 2023 in non-regulated investment opportunities and economic development projects.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:36 am

PRE

Prenetics Global has announced a reverse stock split of its outstanding ordinary shares at a ratio of 1-for-15.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 10:03 am

TIP

Chamath Palihapitiya criticized the U.S. Treasury's plan to borrow $1.592 trillion from the private debt market, calling it a 'huge fiscal and monetary failure of action' between the Treasury and the Fed. Tesla CEO Elon Musk responded, saying 'This won't end well.' Treasury yields have been surging, pushing up the government's borrowing costs. The iShares TIPS Bond ETF (TIP) ended Tuesday's session down 0.25% at $102.80.

Portfolio Pulse from Shanthi Rexaline

November 01, 2023 | 8:22 am

AZN

CLS

Cellectis has announced a strategic collaboration and investment agreement with AstraZeneca worth $245M. The collaboration will leverage Cellectis' gene editing technologies and manufacturing capabilities to develop up to 10 novel cell & gene therapy candidate products. Cellectis will receive up to $245M in cash, with potential for additional milestones, plus tiered royalties.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 7:21 am

WDC

Western Digital has priced its upsized offering of $1.4 billion aggregate principal amount of convertible senior notes due 2028, reflecting an increase of $100 million over the previously announced offering size.

Portfolio Pulse from Benzinga Newsdesk

November 01, 2023 | 7:12 am